Cargando…

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

African horse sickness virus (AHSV) belongs to the genus Orbivirus. We have now engineered naked DNAs and recombinant modified vaccinia virus Ankara (rMVA) expressing VP2 and NS1 proteins from AHSV-4. IFNAR((−/−)) mice inoculated with DNA/rMVA-VP2,-NS1 from AHSV-4 in an heterologous prime-boost vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Poza, Francisco, Calvo-Pinilla, Eva, López-Gil, Elena, Marín-López, Alejandro, Mateos, Francisco, Castillo-Olivares, Javier, Lorenzo, Gema, Ortego, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720900/ https://www.ncbi.nlm.nih.gov/pubmed/23894615 http://dx.doi.org/10.1371/journal.pone.0070197

Ejemplares similares

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
por: Calvo-Pinilla, Eva, et al.
Publicado: (2015)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination
por: Castillo‐Olivares, Javier
Publicado: (2020)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2(1-180)) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2022)

Characterising Non-Structural Protein NS4 of African Horse Sickness Virus
por: Zwart, Lizahn, et al.
Publicado: (2015)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
por: Mathebula, Evans M., et al.
Publicado: (2017)

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2014)

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
por: Kanai, Yuta, et al.
Publicado: (2014)

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2020)

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
por: Lulla, Valeria, et al.
Publicado: (2016)

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
por: Chiam, Rachael, et al.
Publicado: (2009)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness
por: Durán‐Ferrer, Manuel, et al.
Publicado: (2018)

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
por: van de Water, Sandra G. P., et al.
Publicado: (2015)

Association of IFNAR1 and IFNAR2 with COVID-19 severity
por: Yaugel-Novoa, Melyssa, et al.
Publicado: (2023)

Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes
por: Sullivan, Edward, et al.
Publicado: (2021)

Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
por: Wang, Yifan, et al.
Publicado: (2022)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

Serotype Specific Primers and Gel-Based RT-PCR Assays for ‘Typing’ African Horse Sickness Virus: Identification of Strains from Africa
por: Maan, Narender S., et al.
Publicado: (2011)

Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives
por: Jiménez-Cabello, Luis, et al.
Publicado: (2023)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

A review of African horse sickness and its implications for Ireland
por: Thompson, Geoffrey M, et al.
Publicado: (2012)

Seroprevalence of African horse sickness in selected donkey populations in Namibia
por: Molini, Umberto, et al.
Publicado: (2020)

Addressing the recent outbreak of African horse sickness in Lagos, Nigeria
por: Adesola, Ridwan Olamilekan, et al.
Publicado: (2023)

Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination
por: Lorenzo, Gema, et al.
Publicado: (2018)

Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic
por: Meyts, Isabelle
Publicado: (2022)

Horse Sickness
por: Smith, W. Ramsey
Publicado: (1902)

Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa
por: Sergeant, Evan S., et al.
Publicado: (2016)

Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis
por: Backer, Jantien A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q9hkhll75nnujh4guevinjid3k